Status:
COMPLETED
The Efficacy and Safety of Early MSAT on Radiating Pain in the Upper Extremity
Lead Sponsor:
Jaseng Medical Foundation
Conditions:
Radiating Pain in the Upper Extremity
Eligibility:
All Genders
19-69 years
Phase:
NA
Brief Summary
This study is a double blind, randomized controlled trail. condition/disease: radiating pain in the upper extremity. treatment/intervention: motion style acupuncture treatment
Detailed Description
"Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of...
Eligibility Criteria
Inclusion
- Patients aged 19-69 years on the date they sign the consent form.
- Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident.
- Patients who are hospitalized due to traffic accident.
- Patients with NRS of radiating pain ≥ 5.
- Patients who provide consent to participate in the trial and return the informed consent form.
Exclusion
- Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients with progressive neurological deficits or with severe neurological symptoms.
- Patients with medical history of cervical surgery or thoracic surgery within the last three weeks.
- Patients who have radiating pain in upper extremity before the traffic accident.
- Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study.
- If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease.
- Patients who are pregnant or planning to become pregnant.
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement.
- Other patients whose participation in the trial is judged by a researcher to be problematic.
Key Trial Info
Start Date :
November 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06086899
Start Date
November 6 2023
End Date
December 30 2024
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896